The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.
Open accessAbstract
Inflammatory action of the potent chemotaxin C5a has been well characterized on a variety of human cell types, including neutrophils, monocytes, basophils, and eosinophils. The cellular effects of C3a are less well defined. Contradictory reports have been published for C3a activation of neutrophils. Recent reports that C3a activates both basophils and eosinophils prompted us to reinvestigate the effects of C3a stimulation on eosinophils. We hypothesized that C3a activation of eosinophils, cells that are present in most neutrophil preparations, might lead to neutrophil activation. Using neutrophils of 98% purity, we observed no evidence of cellular activation after stimulation with either C3a, recombinant human C3a (rhC3a), or the synthetic C3a analogue C3a 57-77, Y57. Eosinophils purified to > 98% purity displayed concentration-dependent polarization, chemotaxis, and enzyme release by stimulation with C3a, rhC3a, and the synthetic C3a analogue. An inactive form of C3a, C3adesArg, failed to stimulate either eosinophils or neutrophils. Using neutrophil preparations containing 5-9% eosinophils, up to 20% of neutrophils became polarized after exposure to C3a. Likewise, we demonstrated that supernatant from C3a-stimulated eosinophils promotes neutrophil chemotaxis. Eosinophil polarization experiments were repeated in the presence of antibody to the C5a receptor (C5aR) to show that C3a and C5a interact with different receptors. C3a activates eosinophils in the presence of anti-C5aR antibody at concentrations that fully block C5a activation. We conclude that eosinophils are directly activated by either C3a or C5a, whereas C3a failed to activate neutrophils. C3a acts on eosinophils via a receptor that is distinct from C5aR. Since neutrophils are indirectly stimulated by C3a, eosinophils contaminating neutrophil preparations may explain earlier reports that C3a activates human neutrophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils
Hansel, T. T., De Vries, I. J. M., Iff, T., Rihs, S., Wandzilak, M., Betz, S., Blaser, K., & Walker, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90315-7 · Cited by 601
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw, A. J., Moqbel, R., Cromwell, O., & Kay, A. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112765 · Cited by 568
Fernández, H. N., Henson, P. M., Otani, A., & Hugli, T. E. (1978) · PubMed · Cited by 567
Self-citationFerrante, A., & Thong, Y. H. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90036-8 · Cited by 549
Schröder, J. M., Mrowietz, U., Morita, E., & Christophers, E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.10.3474 · Cited by 531
Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase
Bokisch, V. A., & Müller-Eberhard, H. J. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106462 · Cited by 517
Henson, P. M. (1971) · PubMed · Cited by 514
Hugli, T. E., & Müller-Eberhard, H. J. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60228-x · Cited by 499
Self-citationFerrante, A., & Thong, Y. H. (1978) · Journal of Immunological Methods · doi:10.1016/0022-1759(78)90143-6 · Cited by 333
An enzyme in human blood plasma that inactivates bradykinin and kallidins
Erdös, E. G., & Sloane, E. M. (1962) · Biochemical Pharmacology · doi:10.1016/0006-2952(62)90119-3 · Cited by 305
Cited by
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Eosinophils: Biological Properties and Role in Health and Disease
HOGAN, S. P., ROSENBERG, H. F., MOQBEL, R., PHIPPS, S., FOSTER, P. S., LACY, P., KAY, A. B., & ROTHENBERG, M. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02958.x · Cited by 834
Mechanisms of eosinophil-associated inflammation
Gleich, G. J. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.105712 · Cited by 785
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Metadata
- Authors
- Daffern, P. J., Pfeifer, P. H., Ember, J. A., & Hugli, T. E.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-06-01
- Volume
- 181
- Issue
- 6
- Pages
- 2119-2127
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2133008646
- Cited by
- 281
- References
- 38
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. https://app.cochat.ai/papers/10.1084/jem.181.6.2119
- The paper
- Daffern, P. J., Pfeifer, P. H., Ember, J. A., & Hugli, T. E. (1995). C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. The Journal of experimental medicine. https://doi.org/10.1084/jem.181.6.2119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.